BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22520478)

  • 41. [Molecular-targeted drug for non-small cell lung cancer].
    Okamoto I
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():438-42. PubMed ID: 23513880
    [No Abstract]   [Full Text] [Related]  

  • 42. Genomic medicine and targeted therapy for solid tumors.
    Stevens EA; Rodriguez CP
    J Surg Oncol; 2015 Jan; 111(1):38-42. PubMed ID: 25042935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene mutation-based and specific therapies in precision medicine.
    Wang X
    J Cell Mol Med; 2016 Apr; 20(4):577-80. PubMed ID: 26994883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Regional molecular genetics centers in thoracic oncology: what and who should be tested?].
    Barlesi F; Tomasini P; Fina F; Secq V; Greillier L; Nanni-Metellus I; Garcia S; Ouafik L
    Bull Cancer; 2013; 100(7-8):737-41. PubMed ID: 23823903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Molecular targeted cancer therapy and genetic tests --chairman's introductory remarks].
    Hinoda Y
    Rinsho Byori; 2012 Oct; 60(10):967-8. PubMed ID: 23323461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiogenomics predicting tumor responses to radiotherapy in lung cancer.
    Das AK; Bell MH; Nirodi CS; Story MD; Minna JD
    Semin Radiat Oncol; 2010 Jul; 20(3):149-55. PubMed ID: 20685577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multi-targeted approach to cancer treatment: an international translational cancer research symposium.
    Mehta K; Gandhi V; Pathak S; Aggarwal BB; Grover RK
    Anticancer Res; 2014 Nov; 34(11):6791-5. PubMed ID: 25368293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Next Generation of Lung Cancer Management.
    Levy B
    Oncology (Williston Park); 2019 Oct; 33(10):. PubMed ID: 31661148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new concept to broaden access to molecular testing.
    Caffrey MK
    Am J Manag Care; 2014 Mar; 20(5 Spec No.):E5. PubMed ID: 25618619
    [No Abstract]   [Full Text] [Related]  

  • 50. Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer.
    Palmer JD; Zaorsky NG; Witek M; Lu B
    J Thorac Dis; 2014 Apr; 6(4):387-98. PubMed ID: 24688783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of genomic markers that predict response to molecularly targeted antileukemic therapy.
    Raponi M; Harousseau JL
    Expert Opin Med Diagn; 2008 Apr; 2(4):361-72. PubMed ID: 23495705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene expression-based diagnostics for molecular cancer classification of difficult to diagnose tumors.
    Schnabel CA; Erlander MG
    Expert Opin Med Diagn; 2012 Sep; 6(5):407-19. PubMed ID: 23480806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in oncology.
    Ferté C; Trister AD; Huang E; Bot BM; Guinney J; Commo F; Sieberts S; André F; Besse B; Soria JC; Friend SH
    Clin Cancer Res; 2013 Aug; 19(16):4315-25. PubMed ID: 23780890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecularly targeted therapy in neuro-oncology.
    Sathornsumetee S; Rich JN
    Handb Clin Neurol; 2012; 104():255-78. PubMed ID: 22230448
    [No Abstract]   [Full Text] [Related]  

  • 55. [Introduction to the Thematic Series "Targeted therapies in lung cancers"].
    Berghmans T; Mazières J
    Rev Mal Respir; 2015 Apr; 32(4):341-3. PubMed ID: 25957014
    [No Abstract]   [Full Text] [Related]  

  • 56. [Biomarker research and molecular targeting therapy].
    Nakagawa H
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():294-7. PubMed ID: 23513854
    [No Abstract]   [Full Text] [Related]  

  • 57. Keeping pace with cancer.
    Nat Med; 2013 Nov; 19(11):1380. PubMed ID: 24202390
    [No Abstract]   [Full Text] [Related]  

  • 58. Molecular Pathology of Non-Small Cell Lung Cancer.
    Serracino HS; Franklin WA; Aisner DL
    Surg Pathol Clin; 2012 Dec; 5(4):903-18. PubMed ID: 26838508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MD Anderson program shoots for the moon: "Moon Shots" aims to quickly convert scientific advances into effective treatments.
    Printz C
    Cancer; 2012 Dec; 118(24):6015-6. PubMed ID: 23208669
    [No Abstract]   [Full Text] [Related]  

  • 60. [Trend of molecular target therapy of non-small cell lung cancer].
    Liao M
    Zhongguo Fei Ai Za Zhi; 2004 Aug; 7(4):270-5. PubMed ID: 21241541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.